Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Liabilities and Shareholders Equity: 2019-2025

Historic Liabilities and Shareholders Equity for Biodesix (BDSX) over the last 5 years, with Sep 2025 value amounting to $88.7 million.

  • Biodesix's Liabilities and Shareholders Equity fell 13.65% to $88.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $359.9 million, marking a year-over-year decrease of 11.10%. This contributed to the annual value of $97.2 million for FY2024, which is 1.87% down from last year.
  • Biodesix's Liabilities and Shareholders Equity amounted to $88.7 million in Q3 2025, which was up 1.12% from $87.7 million recorded in Q2 2025.
  • Biodesix's 5-year Liabilities and Shareholders Equity high stood at $115.8 million for Q2 2024, and its period low was $61.7 million during Q1 2022.
  • Its 3-year average for Liabilities and Shareholders Equity is $91.8 million, with a median of $87.7 million in 2025.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first surged by 93.35% in 2021, then tumbled by 46.62% in 2022.
  • Quarterly analysis of 5 years shows Biodesix's Liabilities and Shareholders Equity stood at $76.1 million in 2021, then climbed by 22.09% to $92.9 million in 2022, then increased by 6.66% to $99.1 million in 2023, then decreased by 1.87% to $97.2 million in 2024, then decreased by 13.65% to $88.7 million in 2025.
  • Its Liabilities and Shareholders Equity was $88.7 million in Q3 2025, compared to $87.7 million in Q2 2025 and $86.2 million in Q1 2025.